Evidence method
Level · gp.fundamentals.debt_to_revenue
59.34% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TELA · Dec 31, 2024
TELA Bio, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001558370-25-003460General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.43% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-60.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
18.56% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
18.44% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
67.08% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-49.23% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
6.29% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesHistory building
Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/9 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 216.12%
- Current
- 59.34%
- Delta
- -156.78%
- Previous
- 0.64%
- Current
- 1.43%
- Delta
- 0.78%
- Previous
- -47.39%
- Current
- -60.02%
- Delta
- -12.64%
- Previous
- 25.94%
- Current
- 18.56%
- Delta
- -7.39%
- Previous
- 71.74%
- Current
- 18.44%
- Delta
- -53.30%
- Previous
- 67.83%
- Current
- 67.08%
- Delta
- -0.74%
- Previous
- -49.40%
- Current
- -49.23%
- Delta
- 0.17%
- Previous
- 10.91%
- Current
- 12.72%
- Delta
- 1.81%
- Previous
- 5.70%
- Current
- 6.29%
- Delta
- 0.59%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TELA Fundamental State →Has State · TELA Bio, Inc. →Transitioned To · TELA Fundamental State →Transitioned To · TELA BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · TELA CAPEX_INTENSITY_INCREASED →Transitioned To · TELA CASH_GENERATION_DECREASED →Transitioned To · TELA GROWTH_DECREASED →Transitioned To · TELA INVENTORY_PRESSURE_DECREASED →Transitioned To · TELA MARGIN_DECREASED →Transitioned To · TELA PROFITABILITY_INCREASED →Transitioned To · TELA R_AND_D_INTENSITY_INCREASED →Transitioned To · TELA SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.